Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

BIO 2021 Notebook: Looking Past The Pandemic

Annual Meeting Focuses On Post-COVID R&D, Politics And New Opportunities

Jun 14 2021

• By Scrip Team and Pink Sheet Team

BIO 2021 Notebook - Day 1

Related Content

Pondering The Future Of In-Person Meetings At The US FDA

Jun 09 2021

J&J's COVID-19 Vaccine May Face Efficacy Comparison Questions At US FDA Panel Review

Feb 25 2021

GSK/Vir’s Covid Antibody Gains EU Clearance, But Demand May Have Peaked

May 21 2021

Merck’s COVID-19 Therapeutic Development Path Gets A Little Harder

Apr 15 2021

Related Companies

Vir Biotechnology, Inc.

Merck & Co., Inc.

OncoImmune, Inc.

Ridgeback Biotherapeutics LP

Janssen Pharmaceutical Cos.

Alkermes plc

Cerevel Therapeutics Holdings, Inc.

Moderna, Inc.

BioNTech SE

Recursion Pharmaceuticals, Inc.

Additional Topics

Coronavirus COVID-19 FDA Innovation Policy Politics Artificial Intelligence Research & Development Infectious Diseases BioPharmaceutical

More from COVID-19

More from Scrip

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window